Synaptic circuit remodelling by matrix metalloproteinases in health and disease
暂无分享,去创建一个
[1] W. Gan,et al. Sleep contributes to dendritic spine formation and elimination in the developing mouse somatosensory cortex , 2012, Developmental neurobiology.
[2] L. Kaczmarek,et al. Experience-dependent plasticity of the barrel cortex in mice observed with 2-DG brain mapping and c-Fos: effects of MMP-9 KO. , 2012, Cerebral cortex.
[3] Yongchao Ge,et al. Compensatory redistribution of neuroligins and N‐cadherin following deletion of synaptic β1‐integrin , 2012, The Journal of comparative neurology.
[4] B. Reese,et al. Neuronal clustering and fasciculation phenotype in Dscam‐ and Bax‐deficient mouse retinas , 2012, The Journal of comparative neurology.
[5] C. Alberini,et al. Memory enhancement: consolidation, reconsolidation and insulin-like growth factor 2 , 2012, Trends in Neurosciences.
[6] E. Tsilibary,et al. Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over‐expressing MMP9 , 2012, Journal of neurochemistry.
[7] L. Maffei,et al. Inhibition of matrix metalloproteinases prevents the potentiation of nondeprived-eye responses after monocular deprivation in juvenile rats. , 2012, Cerebral cortex.
[8] R. McKay,et al. Matrix Metalloproteinase-9 Regulates Survival of Neurons in Newborn Hippocampus* , 2012, The Journal of Biological Chemistry.
[9] C. Portera-Cailliau. Which Comes First in Fragile X Syndrome, Dendritic Spine Dysgenesis or Defects in Circuit Plasticity? , 2012, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[10] 熊利泽,et al. Neuropathic Pain by Neural Damage to the PNS: A Maladaptive Response of the Nervous System to Damage , 2012 .
[11] T. Bliss,et al. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality , 2012, Nature Reviews Neuroscience.
[12] Ying Zhao,et al. Modafinil treatment prevents REM sleep deprivation-induced brain function impairment by increasing MMP-9 expression , 2011, Brain Research.
[13] P. Kalivas,et al. Integrins Modulate Relapse to Cocaine-Seeking , 2011, The Journal of Neuroscience.
[14] S. Russo,et al. Structural and synaptic plasticity in stress-related disorders , 2011, Reviews in the neurosciences.
[15] Jakub Wlodarczyk,et al. Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology , 2011, Journal of Cell Science.
[16] R. Weinberg,et al. Synaptic Autoregulation by Metalloproteases and γ-Secretase , 2011, The Journal of Neuroscience.
[17] K. Conant,et al. Methamphetamine‐associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule‐5 , 2011, Journal of neurochemistry.
[18] A. Fournier,et al. Membrane-type Matrix Metalloproteinase-3 Regulates Neuronal Responsiveness to Myelin through Nogo-66 Receptor 1 Cleavage* , 2011, The Journal of Biological Chemistry.
[19] K. Broadie,et al. Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase , 2011, Disease Models & Mechanisms.
[20] M. Kossut,et al. Matrix metalloproteinase inhibition counteracts impairment of cortical experience‐dependent plasticity after photothrombotic stroke , 2011, The European journal of neuroscience.
[21] A. Arnsten. Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia , 2011, International Journal of Developmental Neuroscience.
[22] Jeremy M. Henley,et al. Routes, destinations and delays: recent advances in AMPA receptor trafficking , 2011, Trends in Neurosciences.
[23] Y. Zuo,et al. Experience-dependent structural plasticity in the cortex , 2011, Trends in Neurosciences.
[24] Kristen M Harris,et al. Coordination of size and number of excitatory and inhibitory synapses results in a balanced structural plasticity along mature hippocampal CA1 dendrites during LTP , 2011, Hippocampus.
[25] Sarah A. Stern,et al. A critical role for IGF-II in memory consolidation and enhancement , 2011, Nature.
[26] Ingebrigt Sylte,et al. Regulation of matrix metalloproteinase activity in health and disease , 2011, The FEBS journal.
[27] Hiroki Matsumura. Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target , 2011 .
[28] L. Kaczmarek,et al. Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology? , 2010, The Journal of Neuroscience.
[29] Fabian J. Theis,et al. MicroRNA Loss Enhances Learning and Memory in Mice , 2010, The Journal of Neuroscience.
[30] J. Mozrzymas,et al. Late phase of long‐term potentiation in the mossy fiber—CA3 hippocampal pathway is critically dependent on metalloproteinases activity , 2010, Hippocampus.
[31] Erik B. Bloss,et al. Persistence of Coordinated Long-Term Potentiation and Dendritic Spine Enlargement at Mature Hippocampal CA1 Synapses Requires N-Cadherin , 2010, The Journal of Neuroscience.
[32] G. Stanwood,et al. Methamphetamine Reduces LTP and Increases Baseline Synaptic Transmission in the CA1 Region of Mouse Hippocampus , 2010, PloS one.
[33] Wen-tao Liu,et al. Spinal Matrix Metalloproteinase-9 Contributes to Physical Dependence on Morphine in Mice , 2010, The Journal of Neuroscience.
[34] E. Gundelfinger,et al. Converting juvenile into adult plasticity: a role for the brain’s extracellular matrix , 2010, The European journal of neuroscience.
[35] J. Morrison,et al. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens , 2010, Trends in Neurosciences.
[36] Y. Goda,et al. Unraveling Mechanisms of Homeostatic Synaptic Plasticity , 2010, Neuron.
[37] Z. Werb,et al. Matrix Metalloproteinases and Neurotrauma: Evolving Roles in Injury and Reparative Processes , 2010, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[38] M. Mattson,et al. Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation , 2010, Neuroscience.
[39] Gary A Rosenberg,et al. Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia , 2010, Journal of neurochemistry.
[40] L. Kaczmarek,et al. Matrix metalloproteinase‐9 reversibly affects the time course of NMDA‐induced currents in cultured rat hippocampal neurons , 2009, Hippocampus.
[41] J. Chauvin,et al. Differential vesicular distribution and trafficking of MMP‐2, MMP‐9, and their inhibitors in astrocytes , 2009, Glia.
[42] I. Sagi,et al. Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition? , 2010, Biochimica et biophysica acta.
[43] M. Skalski,et al. VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion , 2009, Journal of Cell Science.
[44] J. Wright,et al. Influence of dorsal hippocampal lesions and MMP inhibitors on spontaneous recovery following a habituation/classical conditioning head–shake task , 2009, Neurobiology of Learning and Memory.
[45] Christopher M Overall,et al. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. , 2009, Biochemistry.
[46] J. Harding,et al. Habituation-induced neural plasticity in the hippocampus and prefrontal cortex mediated by MMP-3 , 2009, Behavioural Brain Research.
[47] N. Maeda,et al. Timp-3 deficiency impairs cognitive function in mice , 2009, Laboratory Investigation.
[48] D. Perrais,et al. Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity , 2009, Nature Neuroscience.
[49] Michael Costigan,et al. Neuropathic pain: a maladaptive response of the nervous system to damage. , 2009, Annual review of neuroscience.
[50] L. Kaczmarek,et al. Matrix Metalloproteinase-9 Controls NMDA Receptor Surface Diffusion through Integrin β1 Signaling , 2009, The Journal of Neuroscience.
[51] U. Gerber,et al. Coincident Pre- and Postsynaptic Activation Induces Dendritic Filopodia via Neurotrypsin-Dependent Agrin Cleavage , 2009, Cell.
[52] F. Gomis-Rüth. Catalytic Domain Architecture of Metzincin Metalloproteases* , 2009, The Journal of Biological Chemistry.
[53] J. Montaner,et al. Matrix Metalloproteinase-13 is Activated and is found in the Nucleus of Neural Cells after Cerebral Ischemia , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[54] L. Kaczmarek,et al. High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses , 2009, Neuroscience.
[55] L. Kaczmarek,et al. JunB is a repressor of MMP-9 transcription in depolarized rat brain neurons , 2009, Molecular and Cellular Neuroscience.
[56] L. Kaczmarek,et al. Yin Yang 1 Is a Critical Repressor of Matrix Metalloproteinase-9 Expression in Brain Neurons* , 2008, Journal of Biological Chemistry.
[57] Qiang Zhou,et al. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately , 2008, Proceedings of the National Academy of Sciences.
[58] J. Harding,et al. Increase in matrix metalloproteinase‐9 levels in the rat medial prefrontal cortex after cocaine reinstatement of conditioned place preference , 2008, Synapse.
[59] O. Debeir,et al. Matrix metalloproteinase‐9 interplays with the IGFBP2–IGFII complex to promote cell growth and motility in astrocytomas , 2008, Glia.
[60] A. Gaultier,et al. The Hemopexin Domain of Matrix Metalloproteinase-9 Activates Cell Signaling and Promotes Migration of Schwann Cells by Binding to Low-Density Lipoprotein Receptor-Related Protein , 2008, The Journal of Neuroscience.
[61] J. Chauvin,et al. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells , 2008, Molecular and Cellular Neuroscience.
[62] R. Huganir,et al. MMP‐7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[63] S. Warren,et al. Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function , 2008, Neuron.
[64] Michelle N. Ngo,et al. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model , 2008, Journal of Medical Genetics.
[65] J. Kirsch,et al. Activity-Dependent Shedding of the NMDA Receptor Glycine Binding Site by Matrix Metalloproteinase 3: A PUTATIVE Mechanism of Postsynaptic Plasticity , 2008, PloS one.
[66] Y. Goda,et al. Activity-Dependent Regulation of Synaptic AMPA Receptor Composition and Abundance by β3 Integrins , 2008, Neuron.
[67] M. Frerking,et al. Spine Expansion and Stabilization Associated with Long-Term Potentiation , 2008, The Journal of Neuroscience.
[68] C. Gahmberg,et al. ICAM-5--a novel two-facetted adhesion molecule in the mammalian brain. , 2008, Immunology letters.
[69] Stephen T Warren,et al. Fragile X syndrome , 2008, European Journal of Human Genetics.
[70] Steffen B. E. Wolff,et al. mGluR1/5-Dependent Long-Term Depression Requires the Regulated Ectodomain Cleavage of Neuronal Pentraxin NPR by TACE , 2008, Neuron.
[72] H. Yeh,et al. Synaptic Function for the Nogo-66 Receptor NgR1: Regulation of Dendritic Spine Morphology and Activity-Dependent Synaptic Strength , 2008, The Journal of Neuroscience.
[73] L. Kaczmarek,et al. Important role of matrix metalloproteinase 9 in epileptogenesis , 2008, The Journal of cell biology.
[74] Ping-Heng Tan,et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain , 2008, Nature Medicine.
[75] Mikel L. Olson,et al. Hippocampal MMP-3 elevation is associated with passive avoidance conditioning , 2008, Regulatory Peptides.
[76] Thien Nguyen,et al. Cleavage of myelin associated glycoprotein by matrix metalloproteinases , 2008, Journal of Neuroimmunology.
[77] M. Takigawa,et al. Novel Transcription Factor-Like Function of Human Matrix Metalloproteinase 3 Regulating the CTGF/CCN2 Gene , 2008, Molecular and Cellular Biology.
[78] T. Nabeshima,et al. Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents. , 2008, Journal of pharmacological sciences.
[79] Charles D. Kopec,et al. GluR1 Links Structural and Functional Plasticity at Excitatory Synapses , 2007, The Journal of Neuroscience.
[80] L. Kaczmarek,et al. Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA , 2007, Neuroscience.
[81] R. Malenka,et al. Synaptic plasticity and addiction , 2007, Nature Reviews Neuroscience.
[82] C. Gerfen,et al. Matrix metalloproteinase-7 modulates synaptic vesicle recycling and induces atrophy of neuronal synapses , 2007, Neuroscience.
[83] O. Bozdagi,et al. The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory. , 2007, Learning & memory.
[84] D. Ethell,et al. Matrix metalloproteinases in brain development and remodeling: Synaptic functions and targets , 2007, Journal of neuroscience research.
[85] C. J. Davis,et al. Effects of matrix metalloproteinase inhibition on short‐ and long‐term plasticity of schaffer collateral/CA1 synapses , 2007, Journal of neurochemistry.
[86] T. Jay,et al. TIMP-1 Abolishes MMP-9-Dependent Long-lasting Long-term Potentiation in the Prefrontal Cortex , 2007, Biological Psychiatry.
[87] S. Itohara,et al. Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage , 2007, The Journal of cell biology.
[88] C. Gerfen,et al. Cleavage of neuronal synaptosomal‐associated protein of 25 kDa by exogenous matrix metalloproteinase‐7 , 2007, Journal of neurochemistry.
[89] O. Bozdagi,et al. In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. , 2007, Journal of neurophysiology.
[90] L. Kaczmarek,et al. β-Dystroglycan as a Target for MMP-9, in Response to Enhanced Neuronal Activity* , 2007, Journal of Biological Chemistry.
[91] Andrew J. Ewald,et al. Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.
[92] H. Jansen,et al. Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference. , 2007, Learning & memory.
[93] T. Robinson,et al. Methamphetamine‐induced structural plasticity in the dorsal striatum , 2007, The European journal of neuroscience.
[94] G. Lynch,et al. LTP consolidation: Substrates, explanatory power, and functional significance , 2007, Neuropharmacology.
[95] John W. Wright,et al. Inhibition of Hippocampal Matrix Metalloproteinase-3 and -9 Disrupts Spatial Memory , 2006, Neural plasticity.
[96] S. Itohara,et al. Reduction of methamphetamine‐induced sensitization and reward in matrix metalloproteinase‐2 and ‐9‐deficient mice , 2006, Journal of neurochemistry.
[97] Z. Werb,et al. Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice , 2006, Behavioural Brain Research.
[98] Jonathan R. Whitlock,et al. Learning Induces Long-Term Potentiation in the Hippocampus , 2006, Science.
[99] K. Mori,et al. Telencephalin Slows Spine Maturation , 2006, The Journal of Neuroscience.
[100] I. Ethell,et al. Integrins Control Dendritic Spine Plasticity in Hippocampal Neurons through NMDA Receptor and Ca2+/Calmodulin-Dependent Protein Kinase II-Mediated Actin Reorganization , 2006, The Journal of Neuroscience.
[101] J. Lochner,et al. Activity-dependent release of tissue plasminogen activator from the dendritic spines of hippocampal neurons revealed by live-cell imaging. , 2006, Journal of neurobiology.
[102] G. Lynch,et al. Integrin-driven actin polymerization consolidates long-term potentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[103] D. Rusakov,et al. Matrix metalloproteinase‐7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation , 2006, Journal of neurochemistry.
[104] Sherry L. Niessen,et al. Proteomic profiling of metalloprotease activities with cocktails of active-site probes , 2006, Nature chemical biology.
[105] Mikel L. Olson,et al. Effects of extracellular matrix‐degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity , 2006, Journal of neurochemistry.
[106] E. Ziff,et al. Membrane Localization of Membrane Type 5 Matrix Metalloproteinase by AMPA Receptor Binding Protein and Cleavage of Cadherins , 2006, The Journal of Neuroscience.
[107] Alcino J. Silva,et al. Matrix Metalloproteinase-9 Is Required for Hippocampal Late-Phase Long-Term Potentiation and Memory , 2006, The Journal of Neuroscience.
[108] Roberto Malinow,et al. Glutamate Receptor Exocytosis and Spine Enlargement during Chemically Induced Long-Term Potentiation , 2006, The Journal of Neuroscience.
[109] Ronald L. Davis,et al. β1-Integrins Are Required for Hippocampal AMPA Receptor-Dependent Synaptic Transmission, Synaptic Plasticity, and Working Memory , 2006, The Journal of Neuroscience.
[110] V. Yong,et al. Metalloproteinases: Mediators of Pathology and Regeneration in the CNS , 2005, Nature Reviews Neuroscience.
[111] W. Baumgärtner,et al. Matrix Metalloproteinases and Their Inhibitors in the Developing Mouse Brain and Spinal Cord: A Reverse Transcription Quantitative Polymerase Chain Reaction Study , 2005, Developmental Neuroscience.
[112] F. Roman,et al. Tissue inhibitor of metalloproteinases‐1 (TIMP‐1) modulates neuronal death, axonal plasticity, and learning and memory , 2005, The European journal of neuroscience.
[113] S. Winder,et al. Dystroglycan: a multifunctional adaptor protein , 2005 .
[114] N. Daw,et al. Experience-Driven Plasticity of Visual Cortex Limited by Myelin and Nogo Receptor , 2005, Science.
[115] P. Soloway,et al. Prepulse inhibition and fear-potentiated startle are altered in tissue inhibitor of metalloproteinase-2 (TIMP-2) knockout mice , 2005, Brain Research.
[116] M. Boccia,et al. NF‐κB transcription factor is required for inhibitory avoidance long‐term memory in mice , 2005, The European journal of neuroscience.
[117] H. J. Kim,et al. Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis , 2005, Experimental Neurology.
[118] Gary Lynch,et al. Theta Stimulation Polymerizes Actin in Dendritic Spines of Hippocampus , 2005, The Journal of Neuroscience.
[119] Albert E. Ayoub,et al. Developmental expression of matrix metalloproteinases 2 and 9 and their potential role in the histogenesis of the cerebellar cortex , 2005, The Journal of comparative neurology.
[120] E. Lo,et al. Role of Matrix Metalloproteinases in Delayed Neuronal Damage after Transient Global Cerebral Ischemia , 2004, The Journal of Neuroscience.
[121] K. Arai,et al. Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.
[122] M. Schachner,et al. Extracellular matrix molecules and synaptic plasticity , 2003, Nature Reviews Neuroscience.
[123] G. Lynch,et al. Integrins regulate NMDA receptor-mediated synaptic currents. , 2003, Journal of neurophysiology.
[124] G. Lynch,et al. Integrins Modulate Fast Excitatory Transmission at Hippocampal Synapses* , 2003, The Journal of Biological Chemistry.
[125] S. McFarlane. Metalloproteases Carving Out a Role in Axon Guidance , 2003, Neuron.
[126] Jiankun Cui,et al. S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.
[127] Nasreen S Jessani,et al. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[128] V. Yong,et al. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. , 2002, Brain : a journal of neurology.
[129] G. Serban,et al. A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions , 2002, The EMBO journal.
[130] L. Kaczmarek,et al. Matrix Metalloproteinase-9 Undergoes Expression and Activation during Dendritic Remodeling in Adult Hippocampus , 2002, The Journal of Neuroscience.
[131] G. Buzsáki. Theta Oscillations in the Hippocampus , 2002, Neuron.
[132] J. Krueger,et al. Conditions that affect sleep alter the expression of molecules associated with synaptic plasticity. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[133] G. Lynch,et al. Evidence that integrins contribute to multiple stages in the consolidation of long term potentiation in rat hippocampus , 2001, Neuroscience.
[134] Hiroyuki Arai,et al. Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain‐specific MMP highly expressed in cerebellum , 2001, The European journal of neuroscience.
[135] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[136] R. Yuste,et al. Morphological changes in dendritic spines associated with long-term synaptic plasticity. , 2001, Annual review of neuroscience.
[137] J. Donoghue,et al. Learning-induced LTP in neocortex. , 2000, Science.
[138] O. Bozdagi,et al. Increasing Numbers of Synaptic Puncta during Late-Phase LTP N-Cadherin Is Synthesized, Recruited to Synaptic Sites, and Required for Potentiation , 2000, Neuron.
[139] V. Yong,et al. Interleukin‐1 is a key regulator of matrix metalloproteinase‐9 expression in human neurons in culture and following mouse brain trauma in vivo , 2000, Journal of neuroscience research.
[140] K. Imamura,et al. Neuropsin regulates an early phase of Schaffer‐collateral long‐term potentiation in the murine hippocampus , 2000, The European journal of neuroscience.
[141] D. Jaworski. Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system , 2000, Brain Research.
[142] L. Kaczmarek,et al. Neuronal Excitation-driven and AP-1-dependent Activation of Tissue Inhibitor of Metalloproteinases-1 Gene Expression in Rodent Hippocampus* , 1999, The Journal of Biological Chemistry.
[143] R. Johnston,et al. © 1999 Cancer Research Campaign Article no. bjoc.1998.0291 , 2022 .
[144] Mary Chen,et al. Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway , 1998, Neuron.
[145] Chou P Hung,et al. A Role for the Cadherin Family of Cell Adhesion Molecules in Hippocampal Long-Term Potentiation , 1998, Neuron.
[146] K. Mori,et al. Polarized distribution and cell type‐specific localization of telencephalin, an intercellular adhesion molecule , 1998, Journal of neuroscience research.
[147] Richard M. Napier,et al. Large-Scale Sprouting of Cortical Connections After Peripheral Injury in Adult Macaque Monkeys , 1998 .
[148] D. Buonomano,et al. Cortical plasticity: from synapses to maps. , 1998, Annual review of neuroscience.
[149] S. Mohan,et al. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.
[150] Y. Ben‐Ari,et al. Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Is Differentially Induced in Neurons and Astrocytes after Seizures: Evidence for Developmental, Immediate Early Gene, and Lesion Response , 1997, The Journal of Neuroscience.
[151] I. Izquierdo,et al. Sequential Role of Hippocampus and Amygdala, Entorhinal Cortex and Parietal Cortex in Formation and Retrieval of Memory for Inhibitory Avoidance in Rats , 1997, The European journal of neuroscience.
[152] Z. Werb,et al. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. , 1996, Current opinion in cell biology.
[153] R. Nudo,et al. Neural Substrates for the Effects of Rehabilitative Training on Motor Recovery After Ischemic Infarct , 1996, Science.
[154] Elly Nedivi,et al. Numerous candidate plasticity-related genes revealed by differential cDNA cloning , 1993, Nature.
[155] Eric R. Kandel,et al. Tissue-plasminogen activator is induced as an immediate–early gene during seizure, kindling and long-term potentiation , 1993, Nature.
[156] H. Sato,et al. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. , 1993, Oncogene.
[157] D. Madison,et al. A requirement for the intercellular messenger nitric oxide in long-term potentiation. , 1991, Science.
[158] H. Birkedal‐Hansen,et al. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[159] U. Frey,et al. Anisomycin, an inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro , 1988, Brain Research.